FDA recall D-0771-2021

Hikma Pharmaceuticals USA Inc. · Class III · drug

Product

Bleomycin for Injection, USP, packaged in 15 units per single dose vial, Rx only, Manufactured by Thymoorgan Pharmazie GmbH Schiffgraben 23, 38690 Gosfar, Germany Distributed by Hikma USA Inc. Berkeley Heights, NJ 07922, NDC 0143-9240-01

Reason for recall

Labeling: Not elsewhere classified: Mislabeling

Distribution

USA nationwide

Key facts

Status
Terminated
Initiation date
2021-08-05
Report date
2021-09-01
Termination date
2023-06-08
Voluntary/Mandated
Voluntary: Firm initiated
Location
Cherry Hill, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0771-2021